The HER2 signaling pathway directly regulates cyclin D1 expression, resulting in cell cycle regulation and cancer cell proliferation.34 As shown in figure 6F, cyclin D1 expression was downregulated after HER2-DC1 i.t. and anti-HER2 antibodies combination treatment. Here, ERBB2 is linked to cancer.